Homeopathic medicines for treatment of warts - a small, fleshy bump on the skin or mucous membrane

Role of individualized homeopathic medicines in treatment of warts: A double-blind, randomized, placebo-controlled trial

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/10/021659

Enrollment

Registered

2019-10-16

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B079- Viral wart, unspecified

Interventions

Intervention1: Individualized homeopathic medicines in centesimal potencies and in individualized dosage: Intervention is planned as administering indicated homeopathic medicines in centesimal potenci

dosage and repetition depending upon the individual requirement of the cases. All medicines will be procured from a Good Manufacturing Practice (GMP)-certified firm. Along with the indicated medicine,

dosage and repetition depending upon the individual requirement of the cases. All the patients will be advised to maintain local hygiene. Duration of therapy: 3 months.

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient of 18- 65 years of age 2. Both sexes 3. Patient presenting with cutaneous warts (non-genital) for a variable period of time and have not gone through any treatment for at least 1 month. 4. Patients already undergoing treatment for warts may be recruited on completely stopping medicine and after wash-out phase of 1 month. 5. Literate patients. 6. Signed written informed consent to participate

Exclusion criteria

Exclusion criteria: 1. Ano-genital and genitals warts 2. Individuals already under treatment (medicinal or surgical or both) within 1month for warts. 3. Diagnosed case of unstable, psychiatric illness or any disease affecting quality of life. 4. Immune-compromised patients. 5. Pregnant and lactating women. 6. Substance abuse and/or dependence 7. Patients undergoing homeopathic treatment for any chronic disease within last 6 months

Design outcomes

Primary

Measure	Time frame
Size and number of wartsTimepoint: Baseline, every month up to 3 months	—

Secondary

Measure	Time frame
Dermatological Life Quality Index (DLQI) questionnaire scoresTimepoint: Baseline, every month up to 3 months	—

Countries

India

Contacts

Public ContactSamit Dey

D. N. De Homoeopathic Medical College & Hospital, Govt. of West Bengal

dr.samit@yahoo.com9875371414

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 15, 2026